Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.90
-0.03 (-0.27%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Corvus Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 917 | 1,256 | 1,229 | 575 | 549 | 308 | 217 | 344 | 330 | 114 | 87 | 86 | 71 | 107 | 42 | 40 | 38 | 46 | 76 | 112 | 205 | |
Market Cap Growth (YoY) | 69.49% | 307.29% | 467.13% | 67.27% | 66.28% | 170.95% | 148.22% | 298.31% | 361.98% | 6.75% | 105.98% | 118.11% | 87.62% | 131.36% | -44.49% | -64.73% | -81.44% | -54.94% | -35.30% | 12.29% | 82.63% |
Enterprise Value | 702 | 1,020 | 1,173 | 510 | 476 | 265 | 166 | 302 | 284 | 93 | 62 | 56 | 36 | 74 | 3 | -7 | -15 | -13 | 11 | 40 | 141 |
Last Close Price | 10.90 | 14.94 | 14.63 | 7.70 | 7.37 | 4.00 | 3.18 | 5.35 | 5.28 | 1.82 | 1.78 | 1.76 | 1.46 | 2.29 | 0.91 | 0.85 | 0.82 | 0.99 | 1.64 | 2.41 | 4.84 |
Price Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | - | - | - | - | -5.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
PB Ratio | 4.07 | 5.58 | 5.11 | 9.40 | 7.65 | 3.85 | 4.39 | 10.56 | 26.62 | 2.22 | 2.62 | 2.23 | 1.61 | 2.15 | 0.87 | 0.71 | 0.59 | 0.57 | 0.85 | 1.16 | 1.95 |
P/TBV Ratio | 4.07 | 5.58 | 5.11 | 9.40 | 7.65 | 3.85 | 4.39 | 10.56 | 26.62 | 2.22 | 2.62 | 2.23 | 1.61 | 2.15 | 0.87 | 0.71 | 0.59 | 0.57 | 0.85 | 1.16 | 1.95 |
Financial Efficiency
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.01 | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Net Debt / Equity Ratio | -0.95 | -0.95 | -0.98 | -0.91 | -0.90 | -0.91 | -0.87 | -1.56 | -3.33 | -0.91 | -0.63 | -0.67 | -0.69 | -0.71 | -0.66 | -0.71 | -0.72 | -0.67 | -0.66 | -0.68 | -0.69 |
Net Debt / EBITDA Ratio | 3.77 | 3.77 | 4.93 | 1.30 | 1.67 | 2.07 | 1.38 | 1.85 | 1.65 | 2.00 | 0.92 | 1.11 | 1.33 | 1.18 | 1.04 | 1.26 | 1.43 | 1.82 | 1.76 | 1.74 | 1.76 |
Net Debt / FCF Ratio | 4.74 | 4.74 | 6.71 | 1.69 | 2.01 | 2.53 | 1.51 | 2.00 | 1.87 | 2.19 | 1.00 | 1.08 | 1.16 | 1.25 | 1.11 | 1.46 | 1.76 | 1.93 | 1.73 | 1.79 | 1.90 |
Quick Ratio | 15.88 | 15.88 | 19.65 | 6.09 | 8.18 | 8.78 | 4.79 | 1.47 | 0.90 | 3.55 | 3.30 | 3.96 | 4.41 | 4.72 | 4.21 | 3.99 | 3.59 | 5.63 | 6.84 | 7.22 | 6.78 |
Current Ratio | 16.16 | 16.16 | 19.81 | 6.21 | 8.29 | 8.91 | 4.90 | 1.54 | 0.93 | 3.62 | 3.40 | 4.07 | 4.53 | 4.82 | 4.29 | 4.06 | 3.67 | 5.80 | 6.95 | 7.36 | 6.97 |
Return on Equity (ROE) | -30.83% | -36.28% | -74.13% | -53.46% | -49.39% | 148.42% | -215.45% | -505.60% | -40.31% | -63.30% | -64.15% | -51.19% | -52.90% | -59.99% | -65.01% | -81.79% | -39.33% | -35.52% | -36.52% | -42.36% | |
Return on Assets (ROA) | -19.59% | -22.94% | -40.29% | -31.11% | -34.45% | -38.65% | -31.73% | -29.40% | -28.36% | -36.51% | -28.87% | -25.28% | -24.18% | -25.78% | -18.57% | -35.65% | -17.71% | -17.24% | -14.57% | -19.57% | |
Return on Capital Employed (ROCE) | -25.20% | -25.20% | -19.90% | -69.60% | -53.70% | -43.90% | -62.20% | -82.20% | -202.00% | -45.60% | -69.10% | -60.30% | -52.00% | -59.70% | -62.60% | -55.60% | -49.90% | -36.10% | -37.10% | -38.50% | -38.50% |
Yields
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Earnings Yield | -5.90% | -4.31% | -3.59% | -2.66% | -2.74% | -14.63% | -19.11% | -18.12% | -17.21% | -19.87% | -28.48% | -31.32% | -42.23% | -36.59% | -96.47% | -104.39% | -106.88% | -79.34% | -52.34% | -38.55% | -3.24% |
FCF Yield | -4.93% | -3.60% | -2.86% | -5.73% | -5.87% | -9.39% | -13.18% | -7.40% | -6.70% | -18.66% | -24.04% | -27.77% | -36.86% | -26.36% | -68.46% | -68.97% | -69.83% | -60.39% | -45.00% | -32.73% | -18.54% |
Buyback Yield / Dilution | -22.16% | -18.76% | -19.75% | -21.38% | -24.19% | -30.25% | -53.25% | -39.37% | -36.20% | -25.71% | -5.33% | -5.34% | -5.19% | -2.03% | -0.01% | -0.00% | -5.93% | -10.19% | -34.88% | -57.41% | -48.97% |